News
ACROSS the UK, waistlines are shrinking – and it’s not down to willpower alone. Ozempic-like weight-loss jabs have been ...
Researchers at Syracuse University have identified a brain peptide, TDN, that effectively curbs appetite and enhances glucose ...
SALT LAKE CITY — It was a first-of-its-kind study conducted at the University of Utah on a drug that has, to date, changed ...
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to 10–16% (from 16-24%) and revenue growth projections to 8-14% (from 13-21%) at ...
Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...
Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 medications.
Over time, these drugs have also been found to help people lose weight by slowing digestion, reducing hunger, and making ...
An astonishing new trial suggests that Ozempic may help users not only drop pounds but also turn back time. In the first trial to directly measure the impact of semaglutide on aging, half of the ...
These new supplemental products are offering similar benefits to drugs like Ozempic — but experts say it may be a placebo effect.
Some restaurants are offering smaller menu items to GLP-1 drug users, who eat less when dining out, per The New York Times.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results